FDA to Revoke Orphan Designation for Opioid Addiction Drug Sublocade

FDA to Revoke Orphan Designation for Opioid Addiction Drug Sublocade

Source: 
RAPS.org
snippet: 

The US Food and Drug Administration (FDA) said Thursday that it has decided to revoke the orphan designation granted to Indivior’s opioid use disorder (OUD) treatment Sublocade (buprenorphine extended-release injection).